|
|
楼主 |
发表于 2025-1-9 17:21:59
|
显示全部楼层
还统计少了，华西医院牵头是25项 " ^/ n& j- x" F8 U" g! T5 _) o! a7 \
01.Risk factors of complications after inguinal lymph node dissection in patients with penile cancer.0 M4 a! @( X8 N! F3 e1 F
02.Tislelizumab in combination with abiraterone/enzalutamide for metastatic castration-resistant prostate cancer with intraductal adenocarcinoma of the prostate after progression on prior androgen receptor pathway inhibitor.3 O/ i. `( b- C' F$ w
03.Discordance in HER2 expression in primary and recurrent/metastatic lesions of upper tract urothelial carcinoma: A study focusing on temporal heterogeneity.
2 U1 ^* ~! J8 K2 ~! O( ~! W' }04.The impact of neoadjuvant therapy on the formation of tertiary lymphatic structures and the distinct prognosis in prostate cancer.% Z/ h9 \9 [' q2 |& n; t& i7 J
05.Phenotypic and genetically predicted leukocyte telomere length and prostate cancer risk: Results from a large-scale longitudinal cohort study.4 m4 P3 G" |' {! |( J* z
06.Survival impact of concomitant squamous differentiation in upper tract urothelial carcinoma patients receiving adjuvant chemotherapy.: Z9 a* e( U: s: z7 |; F. a! A( z
07.Pathological subclassification of T3 upper tract urothelial carcinoma: Complementary evidence for existing guidelines.0 T0 R: Q, h& M* r$ C8 @2 Y& ], f1 r
08.Evaluating the efficacy and safety of pelvic lymph node dissection in high-risk prostate cancer patients undergoing radical prostatectomy: A systematic review and meta-analysis.$ y1 J4 k5 ~ r/ K" }& i. [
09.Safety and efficacy of immune checkpoint inhibitor rechallenge in metastatic fumarate hydratase-deficient renal cell carcinoma: A retrospective study.
& |2 }6 o) E$ D8 D10.Interpretable machine learning for prostate biopsy: Cohort study.+ [, M% Y0 v. Z0 g& x. M f) D
11.Genomic features of prostate cancer patients with and without ductal adenocarcinoma (DA) based on liquid biopsy.
# C2 |) W: M/ `/ }4 @12.Clinicopathological features and prognosis of MED15-TFE3 rearrangement renal cell carcinoma: An updated report.
& Z! u4 U Z3 b3 A13.Long-term results of a phase 2 study of neoadjuvant chemotherapy combined with tislelizumab followed by radiotherapy for bladder-preserving treatment in selected high-risk/locally advanced muscle invasive urothelial bladder cancer (HOPE-02).! m' c# h, p, {: u i2 o
14.A multi-center phase Ib/II study of RC48-ADC combined with tislelizumab as neoadjuvant treatment in patients with HER2 positive locally advanced muscle-invasive urothelial bladder cancer (Hope-03).2 N; P% l& y6 I
15.VORSIN-RCC: Vorolanib plus sintilimab for advanced renal cell carcinoma after failure of prior immune checkpoint inhibitors-based combination therapy./ i% H1 ]; M1 H6 [
16.Cadonilimab (anti-PD-1 and CTLA-4 bispecific antibody) combined with axitinib for the first-line treatment of advanced or metastatic non-clear renal cell carcinoma: A prospective, single-arm, phase Ib/II study." o4 f7 K$ X: }3 S) O% V
17.Kidney-sparing approach for selected localized high-risk upper tract urothelial carcinoma: A pilot study combining endoscopic thulium laser ablation with perioperative disitamab vedotin and immune checkpoint inhibitors." M8 N9 \3 K: z/ f# b8 q
18.Comprehensive modalities of kidney-sparing treatment in a carefully selected cohort of localized high-risk upper tract urothelial carcinoma: A potential paradigm shift.
: U) V& j; d2 }% a0 P1 Y$ M19.Efficacy of systemic treatments for advanced non-clear cell renal cell carcinoma: A single-arm systematic review and meta-analysis.8 c) S! o; j+ P* p! k
20.The prognostic significance of prostate-specific antigen dynamics during abiraterone therapy in patients with high-risk metastatic hormone-sensitive prostate cancer.
0 r. r, u8 A, Q, P5 H21.Global spatiotemporal trends in prostate cancer burden and its socioeconomic disparities: An observational study from 1990 to 2021.( O: z1 d1 @& S6 f
22.Optimizing the strategies to perform prostate biopsy in MRI-positive patients: A systematic review and network meta-analysis.
9 n. X' o: t j6 F23.Assessment of the proficiency of ChatGPT-4o in an image-based robot-assisted radical prostatectomy scenario./ n O3 M( [ x7 S
24.The prognostic significance of circulating tumor DNA in prostate cancer: A systematic review and meta-analysis.1 {- Y$ H% F8 m- y6 y$ O, \: H
25.Global and regional burden of kidney cancer: Analysis and future predictions based on GBD data from 1990 to 2021.# `, M! d$ c i( ]
|
|
发表于 2025-1-9 15:59:44
发表于 2025-1-9 17:01:32
看年内重离子质子医院投运后，能否发起追赶
